ArticleFrontiers in pharmacology2022

Active Tumor-Targeting Nano-formulations Containing Simvastatin and Doxorubicin Inhibit Melanoma Growth and Angiogenesis.

Giorgiana Negrea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.